Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Explore how low bioburden powders for terminal sterilization support sterile drug development, improve contamination control, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results